View Future GrowthS.C. Helios 과거 순이익 실적과거 기준 점검 4/6S.C. Helios은 연평균 18.5%의 비율로 수입이 증가해 온 반면, Basic Materials 산업은 수입이 0.5% 감소했습니다. 매출은 연평균 2.2%의 비율로 증가했습니다. S.C. Helios의 자기자본이익률은 10.8%이고 순이익률은 17.5%입니다.핵심 정보18.50%순이익 성장률17.78%주당순이익(EPS) 성장률Basic Materials 산업 성장률8.23%매출 성장률2.18%자기자본이익률10.80%순이익률17.45%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • Apr 09No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Mar 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공지 • Mar 06S.C. Helios S.A., Annual General Meeting, Apr 06, 2026S.C. Helios S.A., Annual General Meeting, Apr 06, 2026.Board Change • Jan 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON23.60, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 15x in the Basic Materials industry in Europe. Total returns to shareholders of 18% over the past year.분석 기사 • Nov 21Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance CompletelyS.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...분석 기사 • Nov 12We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to RON21.00, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 15x in the Basic Materials industry in Europe.분석 기사 • Oct 07S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...분석 기사 • Oct 07S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 16x in the Basic Materials industry in Europe.분석 기사 • Jun 12S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Board Change • May 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.분석 기사 • Apr 26Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% BounceThose holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...분석 기사 • Apr 21S.C. Helios (BVB:HEAL) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 25%After last week's 25% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 17x in the Basic Materials industry in Romania. Total returns to shareholders of 122% over the past year.New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (RON23.6m market cap, or US$5.16m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).공지 • Mar 08S.C. Helios S.A., Annual General Meeting, Apr 08, 2025S.C. Helios S.A., Annual General Meeting, Apr 08, 2025.분석 기사 • Feb 25Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% CheaperThe S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to RON21.60, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 47x in the Basic Materials industry in Romania. Total returns to shareholders of 167% over the past year.분석 기사 • Dec 30S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 48x in the Basic Materials industry in Romania.Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to RON19.00, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 19x in the Basic Materials industry in Romania.분석 기사 • Nov 10S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 40%After last week's 40% share price gain to RON12.50, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 19x in the Basic Materials industry in Romania.분석 기사 • Nov 03S.C. Helios (BVB:HEAL) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Board Change • Oct 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.분석 기사 • Sep 03A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share PriceWith a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...Board Change • Aug 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON8.95, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 24x in the Basic Materials industry in Romania.분석 기사 • May 21Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to RON6.50, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 10x in the Basic Materials industry in Romania.매출 및 비용 세부 내역S.C. Helios가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BVB:HEAL 매출, 비용 및 순이익 (RON Millions)날짜매출순이익일반관리비연구개발비31 Dec 253267030 Sep 253257030 Jun 253257031 Mar 253356001 Jan 253456001 Oct 243456030 Jun 243546031 Mar 243536001 Jan 243536001 Oct 233636030 Jun 233726031 Mar 233736001 Jan 233836030 Sep 223536030 Jun 223236031 Mar 223036001 Jan 222936001 Oct 213036030 Jun 213126031 Mar 212925001 Jan 212825001 Oct 202625030 Jun 202415031 Mar 202415001 Jan 202525001 Oct 192525030 Jun 192514031 Mar 192514031 Dec 182514030 Sep 182614030 Jun 182814031 Mar 182814001 Jan 182814001 Oct 172714030 Jun 172614031 Mar 172614001 Jan 172514001 Oct 162513030 Jun 162413031 Mar 162513001 Jan 162513001 Oct 152513030 Jun 1524130양질의 수익: HEAL는 고품질 수익을 보유하고 있습니다.이익 마진 증가: HEAL의 현재 순 이익률 (17.5%)은 지난해 (15.6%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: HEAL의 수익은 지난 5년 동안 연평균 18.5% 증가했습니다.성장 가속화: 지난 1년간 HEAL 의 수익 증가율(5.3%)은 5년 평균(연간 18.5%)보다 낮습니다.수익 대 산업: HEAL의 지난 1년 수익 증가율(5.3%)은 Basic Materials 업계의 -2.2%를 상회했습니다.자기자본이익률높은 ROE: HEAL의 자본 수익률(10.8%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/09 13:03종가2026/04/24 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스S.C. Helios S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Board Change • Apr 09No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Mar 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공지 • Mar 06S.C. Helios S.A., Annual General Meeting, Apr 06, 2026S.C. Helios S.A., Annual General Meeting, Apr 06, 2026.
Board Change • Jan 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON23.60, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 15x in the Basic Materials industry in Europe. Total returns to shareholders of 18% over the past year.
분석 기사 • Nov 21Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance CompletelyS.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...
분석 기사 • Nov 12We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to RON21.00, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 15x in the Basic Materials industry in Europe.
분석 기사 • Oct 07S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
분석 기사 • Oct 07S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 16x in the Basic Materials industry in Europe.
분석 기사 • Jun 12S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Board Change • May 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
분석 기사 • Apr 26Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% BounceThose holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...
분석 기사 • Apr 21S.C. Helios (BVB:HEAL) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 25%After last week's 25% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 17x in the Basic Materials industry in Romania. Total returns to shareholders of 122% over the past year.
New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (RON23.6m market cap, or US$5.16m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
공지 • Mar 08S.C. Helios S.A., Annual General Meeting, Apr 08, 2025S.C. Helios S.A., Annual General Meeting, Apr 08, 2025.
분석 기사 • Feb 25Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% CheaperThe S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to RON21.60, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 47x in the Basic Materials industry in Romania. Total returns to shareholders of 167% over the past year.
분석 기사 • Dec 30S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 48x in the Basic Materials industry in Romania.
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to RON19.00, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 19x in the Basic Materials industry in Romania.
분석 기사 • Nov 10S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 40%After last week's 40% share price gain to RON12.50, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 19x in the Basic Materials industry in Romania.
분석 기사 • Nov 03S.C. Helios (BVB:HEAL) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Board Change • Oct 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
분석 기사 • Sep 03A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share PriceWith a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...
Board Change • Aug 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON8.95, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 24x in the Basic Materials industry in Romania.
분석 기사 • May 21Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...
Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to RON6.50, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 10x in the Basic Materials industry in Romania.